Cohen EE - Search Results

1

Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.

Cohen EE, Halpern AB, Kasza K, Kocherginsky M, Williams R, Vokes EE. Cohen EE, et al. Oral Oncol. 2009 Oct;45(10):e155-60. doi: 10.1016/j.oraloncology.2009.05.637. Epub 2009 Jul 7. Oral Oncol. 2009. PMID: 19586795 Free PMC article. Clinical Trial.

2

Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.

Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ. Salama JK, et al. Among authors: cohen ee. Arch Otolaryngol Head Neck Surg. 2008 Oct;134(10):1060-5. doi: 10.1001/archotol.134.10.1060. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18936351

3

Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.

Mouw KW, Haraf DJ, Stenson KM, Cohen EE, Xi X, Witt ME, List M, Blair EA, Vokes EE, Salama JK. Mouw KW, et al. Among authors: cohen ee. Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1226-34. doi: 10.1001/archoto.2010.218. Arch Otolaryngol Head Neck Surg. 2010. PMID: 21173372

4

Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.

Kuo WL, Liu J, Mauceri H, Vokes EE, Weichselbaum R, Rosner MR, Cohen EE. Kuo WL, et al. Among authors: cohen ee. Mol Cancer Ther. 2010 Oct;9(10):2814-24. doi: 10.1158/1535-7163.MCT-10-0352. Epub 2010 Sep 28. Mol Cancer Ther. 2010. PMID: 20876745 Free PMC article.

5

Mechanisms of resistance to EGFR inhibitors in head and neck cancer.

Cooper JB, Cohen EE. Cooper JB, et al. Among authors: cohen ee. Head Neck. 2009 Aug;31(8):1086-94. doi: 10.1002/hed.21109. Head Neck. 2009. PMID: 19378324 Review.

6

Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.

Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C, Martin LE, Rosner MR. Cohen EE, et al. Cancer Res. 2006 Jun 15;66(12):6296-303. doi: 10.1158/0008-5472.CAN-05-3139. Cancer Res. 2006. PMID: 16778206

7

Personalizing cancer care: updates on head and neck cancer.

de Souza JA, Cohen EE. de Souza JA, et al. Among authors: cohen ee. Expert Rev Anticancer Ther. 2009 Sep;9(9):1219-22. doi: 10.1586/era.09.101. Expert Rev Anticancer Ther. 2009. PMID: 19761425

8

Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab.

Kamaria M, Shea CR, Chin RK, Cohen EE, Maggiore R, Bolotin D. Kamaria M, et al. Among authors: cohen ee. Clin Exp Dermatol. 2014 Jul;39(5):604-7. doi: 10.1111/ced.12341. Epub 2014 Apr 23. Clin Exp Dermatol. 2014. PMID: 24758726

9

mTOR inhibitors.

Cohen E. Cohen E. Clin Adv Hematol Oncol. 2006 Jan;4(1):38-9. Clin Adv Hematol Oncol. 2006. PMID: 16562369 Review. No abstract available.

10

Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin.

Liu J, Kuo WL, Seiwert TY, Lingen M, Ciaccio MF, Jones RB, Rosner MR, Cohen EE. Liu J, et al. Among authors: cohen ee. Head Neck. 2011 Dec;33(12):1774-82. doi: 10.1002/hed.21701. Epub 2011 Mar 24. Head Neck. 2011. PMID: 21438065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters